Nitraattien vaikutus matalapaineglaukoomassa
This study, called "The effect of nitrates in normal tension glaucoma," is helping us understand how a specific medication (Ismox 20 mg tablets) might make a difference for people with normal tension glaucoma. This condition can damage the nerve at the back of the eye, affecting your vision, even when eye pressure is normal. Researchers are using special scans of the eye nerve over 18 months to see if the tablet helps prevent it from getting thinner. They'll compare this to a standard treatment. They're also checking how the participants' vision fields change, if they need more glaucoma treatment, and looking at any side effects from the medication. This is a Phase IV study, meaning the treatment is already approved but they are gathering more information about its effects.
At a glance
What is this study about?
Normal tension glaucoma is a condition where the nerve at the back of your eye, called the optic nerve, gets damaged. This damage can lead to problems with your vision, but it's a bit of a mystery because it happens even when the pressure inside your eye is within the normal range. Other types of glaucoma are usually linked to high eye pressure, which doctors can treat. Because normal tension glaucoma isn't simply about pressure, researchers are looking into other ways to protect the optic nerve and prevent vision loss.
This study, officially titled "The effect of nitrates in normal tension glaucoma," is investigating whether a specific tablet (Ismox 20 mg) containing a nitrate can help. Nitrates are a type of medicine that can improve blood flow, and researchers believe this might be beneficial for the optic nerve. The main goal is to see if this tablet can slow down or stop the nerve from thinning over an 18-month period, compared to people receiving standard care for their condition. They will use a special scanning device to measure the thickness of the nerve fibres at the back of the eye.
Beyond just the nerve thickness, the study will also look at other important details. For instance, they'll check if the tablet helps to keep your field of vision stable and if participants need fewer additional treatments for their glaucoma. They'll also carefully monitor for any side effects from the medication, as patient safety and comfort are always a top priority.
Key takeaways
- The study explores a new treatment for normal tension glaucoma.
- It aims to protect the optic nerve from damage.
- The research involves taking a daily nitrate tablet.
- Participants will have regular eye checks for 18 months.
- It’s a Phase IV study, meaning the medicine is already approved for some uses.
Who may be eligible?
To join this study, participants must be at least 18 years old. Both men and women are welcome to take part. The study is specifically for individuals who have been diagnosed with normal tension glaucoma.
More detailed criteria about your specific eye health and general medical history would be discussed by the study team. This is to make sure the study is a good fit for you and that taking part would be safe.
It's important to have a chat with your doctor if you think you meet these general criteria and are interested in learning more. They can help determine if this study is potentially suitable for you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you have a diagnosis of normal tension glaucoma?
- Are you able to attend regular appointments for 18 months?
- Are you willing to take a daily study medication?
What does participation involve?
If you decide to take part in this study, you would be taking a tablet called Ismox 20 mg (or a similar product known as YA product code 80746) every day. The study will last for a total of 18 months. During this time, you would have several study visits at regular intervals. At these visits, a key assessment will be a special scan of your optic nerve, called optical coherence tomography (OCT), which helps measure the thickness of the nerve fibres.
Besides the nerve scans, you would also have other routine eye check-ups, like vision field tests, to monitor your overall eye health. You might also be asked to keep a diary of any symptoms or side effects you experience, to help the researchers understand how you're feeling and how the medicine is affecting you. These visits and assessments are important for tracking how the treatment is working and for your safety. Full details of the visit schedule and what each visit involves would be explained before you agree to participate.
Potential risks and benefits
Locations (1)
- —UnverifiedFinland
Common questions
What is normal tension glaucoma?
It's a type of glaucoma where the nerve at the back of your eye gets damaged, causing vision problems, even though the pressure inside your eye is normal.
What kind of medicine are they testing?
They're testing a nitrate tablet called Ismox 20 mg, which is thought to help improve blood flow to the optic nerve.
How long will the study last?
The study will last for 18 months, with regular check-ups during that time.
What will I have to do if I join?
You'll take the study tablet daily and attend regular appointments for eye scans and other tests to check your vision and nerve health.
Can I stop participating if I want to?
Yes, you can leave the study at any time, for any reason, and it won't affect your regular medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.